Correlation Between DiaMedica Therapeutics and Marinus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Marinus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Marinus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Marinus Pharmaceuticals, you can compare the effects of market volatilities on DiaMedica Therapeutics and Marinus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Marinus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Marinus Pharmaceuticals.
Diversification Opportunities for DiaMedica Therapeutics and Marinus Pharmaceuticals
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and Marinus is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Marinus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marinus Pharmaceuticals and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Marinus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marinus Pharmaceuticals has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Marinus Pharmaceuticals go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Marinus Pharmaceuticals
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.64 times more return on investment than Marinus Pharmaceuticals. However, DiaMedica Therapeutics is 1.57 times less risky than Marinus Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Marinus Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 154.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 362.00 from holding DiaMedica Therapeutics or generate 235.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Marinus Pharmaceuticals
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Marinus Pharmaceuticals |
DiaMedica Therapeutics and Marinus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Marinus Pharmaceuticals
The main advantage of trading using opposite DiaMedica Therapeutics and Marinus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Marinus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marinus Pharmaceuticals will offset losses from the drop in Marinus Pharmaceuticals' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Marinus Pharmaceuticals vs. Equillium | Marinus Pharmaceuticals vs. DiaMedica Therapeutics | Marinus Pharmaceuticals vs. Valneva SE ADR | Marinus Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |